OTCMKTS:FSNUY Fresenius SE & Co. KGaA (FSNUY) Stock Price, News & Analysis → The 2024 Gold Rush: Unleashing Market Potential (From Priority Gold) (Ad) Free FSNUY Stock Alerts $7.80 +0.17 (+2.25%) (As of 05/10/2024 08:56 PM ET) Add Compare Share Share Today's Range$7.68▼$7.8650-Day Range$6.63▼$7.8052-Week Range$6.33▼$8.38Volume14,300 shsAverage Volume43,788 shsMarket Capitalization$17.43 billionP/E Ratio70.93Dividend Yield2.18%Price TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartDividendEarningsHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartDividendEarningsHeadlinesShort Interest Get Fresenius SE & Co. KGaA alerts: Email Address Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… About Fresenius SE & Co. KGaA Stock (OTCMKTS:FSNUY)Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.Read More FSNUY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart FSNUY Stock News HeadlinesMay 8, 2024 | msn.comFresenius Lifts Guidance On Net Profit BeatMay 8, 2024 | nasdaq.comFresenius Raises FY24 OutlookMay 13, 2024 | Crypto 101 Media (Ad)Tech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. May 7, 2024 | bloomberg.comFresenius Boosts Forecast, Confirms Plans to Exit Vamed BusinessMay 7, 2024 | markets.businessinsider.comEQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius raises outlook for fiscal year 2024May 1, 2024 | msn.comCVS Health Non-GAAP EPS of $1.31 misses by $0.39, revenue of $88.4B misses by $800MApril 19, 2024 | wsj.comFresenius SE & Co. KGaA ADRApril 16, 2024 | finance.yahoo.comUPDATE 1-STOXX 600 nears six-week low on geopolitical jitters; Ericsson shinesMay 13, 2024 | Crypto 101 Media (Ad)Tech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. April 4, 2024 | finance.yahoo.comIs Now The Time To Look At Buying Fresenius SE & Co. KGaA (ETR:FRE)?March 8, 2024 | marketwatch.comFresenius Extends Contract of Finance Chief Sara HennickenFebruary 21, 2024 | msn.comGermany's Fresenius slips into red after unbundling of dialysis unitFebruary 21, 2024 | reuters.comHealthcare group Fresenius tops Q4 operating profit expectationsFebruary 20, 2024 | msn.comFresenius Medical Care Non-GAAP EPS of €0.88, revenue of €4.99B; initiates FY24 outlookFebruary 20, 2024 | markets.businessinsider.comFresenius Medical Care Q4 Profit Climbs, Lifts Dividend; Sees Growth In FY24; Backs FY25 ViewFebruary 20, 2024 | marketwatch.comFresenius Medical Care 4Q Net Pft EUR188MFebruary 5, 2024 | msn.comCigna upgraded at Cantor, RBC on Q4 results, Medicare saleJanuary 15, 2024 | msn.comFresenius perfectly positioned to combat health inequality, says CEOJanuary 8, 2024 | marketwatch.comFresenius Medical Care to Get About $547 Mln From Asset SalesDecember 15, 2023 | finance.yahoo.comFresenius SE & Co. KGaA (FSNUY)December 8, 2023 | msn.comFresenius plans to sell rehabilitation care clinics - FAZDecember 6, 2023 | msn.comFresenius Medical Care says data on 500,000 people stolen in U.S.December 6, 2023 | marketwatch.comFresenius Suspends 2023 Dividend After Using German Relief PackageDecember 6, 2023 | msn.comFresenius Medical Care says data on 500,000 people stolen in U.SNovember 28, 2023 | entrepreneur.comTop 3 Medical Stocks Diagnosing Weekly Potential for ProfitNovember 22, 2023 | markets.businessinsider.comFresenius Medical Care Enters Into Settlement Agreement With U.S.; Raises Annual Earnings OutlookNovember 22, 2023 | finance.yahoo.comIndividual investors account for 43% of Fresenius SE & Co. KGaA's (ETR:FRE) ownership, while institutions account for 30%See More Headlines Receive FSNUY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fresenius SE & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/06/2021Today5/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolOTCMKTS:FSNUY CUSIPN/A CIKN/A Webwww.fresenius.com Phone(496) 172-6080FaxN/AEmployees316,920Year Founded1912Profitability EPS (Most Recent Fiscal Year)$0.11 Trailing P/E Ratio70.93 Forward P/E Ratio9.18 P/E GrowthN/ANet Income$-639,610,000.00 Net Margins0.71% Pretax Margin4.80% Return on Equity4.88% Return on Assets2.02% Debt Debt-to-Equity Ratio0.36 Current Ratio1.54 Quick Ratio1.44 Sales & Book Value Annual Sales$24.01 billion Price / Sales0.73 Cash Flow$2.20 per share Price / Cash Flow3.55 Book Value$15.07 per share Price / Book0.52Miscellaneous Outstanding Shares2,234,010,000Free FloatN/AMarket Cap$17.43 billion OptionableNot Optionable Beta1.07 Social Links The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Michael Sen (Age 56)CEO, President & Chairman of Management Board - Fresenius Management SE Comp: $4.34MMs. Sara Lisa Hennicken (Age 44)CFO & Member of the Management Board - Fresenius Management SE Comp: $1.64MMr. Pierluigi AntonelliMember of Management Board of Fresenius Management SE & CEO of Fresenius KabiDr. Michael Sven Moser Ph.D. (Age 46)Member of Management Board of Fresenius Management SE Comp: $1.27MMr. Robert Moller (Age 53)Member of the Management Board of Fresenius Management SE Comp: $1.22MMr. Markus GeorgiSenior Vice President of Investor RelationsMatthias LinkSenior Vice President Corporate CommunicationsMore ExecutivesKey CompetitorsBaxter InternationalNYSE:BAXInsuletNASDAQ:PODDShockwave MedicalNASDAQ:SWAVSolventumNYSE:SOLVTeleflexNYSE:TFXView All Competitors FSNUY Stock Analysis - Frequently Asked Questions Should I buy or sell Fresenius SE & Co. KGaA stock right now? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fresenius SE & Co. KGaA in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" FSNUY shares. View FSNUY analyst ratings or view top-rated stocks. How have FSNUY shares performed in 2024? Fresenius SE & Co. KGaA's stock was trading at $7.7250 at the beginning of 2024. Since then, FSNUY stock has increased by 1.0% and is now trading at $7.8016. View the best growth stocks for 2024 here. Are investors shorting Fresenius SE & Co. KGaA? Fresenius SE & Co. KGaA saw a increase in short interest in April. As of April 30th, there was short interest totaling 85,500 shares, an increase of 129.2% from the April 15th total of 37,300 shares. Based on an average daily volume of 132,600 shares, the days-to-cover ratio is presently 0.6 days. View Fresenius SE & Co. KGaA's Short Interest. How were Fresenius SE & Co. KGaA's earnings last quarter? Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) posted its earnings results on Thursday, May, 6th. The company reported $0.24 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.23 by $0.01. The firm earned $10.83 billion during the quarter. Fresenius SE & Co. KGaA had a trailing twelve-month return on equity of 4.88% and a net margin of 0.71%. Is Fresenius SE & Co. KGaA a good dividend stock? Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) pays an annual dividend of $0.17 per share and currently has a dividend yield of 2.15%. The dividend payout ratio is 154.56%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, FSNUY will have a dividend payout ratio of 17.00% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for FSNUY. How do I buy shares of Fresenius SE & Co. KGaA? Shares of FSNUY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:FSNUY) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe Crypto 9-5 Escape PlanCrypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressElon’s New Device is About to Shock the WorldInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fresenius SE & Co. KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.